Interesting and predictable response.The repitition continues on...

Interesting and predictable response.
The repitition continues on why Dr T uses HC.

BTW I never wrote that you thought Bisantrene was no good.
I ask you some specific questions on your thoughts on Bisantrene.
...and apparently you cannot answer them.


I cannot tell you how much influence Dr T has on other peoples investment decisions and I don't care.
Dr T declares his position and all investors should own their decision to invest or not.

This rubbish about protecting people's interests is a woke attitude and needs to stop.
No one should get medals for participating, or surviving, because that actually damages society.
People should be rewarded for their outstanding contribution and taking calculated risks in life to contribute to society and their families.
Failure, breeds resiliance and education, something I think we lack in Australia.

Anyway for mine, I have been invested in Race since Jan 2020.
I believe I learned about Race from Wombat, rest his soul.
I first saw Race at 12c but had no funds, so my first investment was at 20c.
I didn't know Dr T at the time.
Mid 2020 City of Hope released a paper on FTO and the most effective molecule, Bisantrene.
That's when a number of contributors, including Dr T helped me understand the science a little better.

If you think I am a Dr T groupie then you are are wrong, but I am a fan.
I am a fan because he has a go and takes those calculated risks.
He is certianly not perfect. The journey is something like this...

• Race had 3 pillars.
• The Race had 5 pillars.
• Then CP was discovered.
• There was a hiccup at board level.
• Now we recently learn there is likely MOP.

Did Dr T make perfect decisions on this journey?
Well that is simply not possible.
I have run my own business for nearly 23 years and still make mistakes, mainly because I am attempting new strategies. Any practical business book would teach you that.

From Dr T I learn some technical and more importantly commerical data about the chances of success.
Having a great molecule does not equal a successful commercial outcome. Ask Lederle about that.
From Mason and Boffin and many others I am being more technically educated.

Most of what Dr T comments on provides clarification and colour on what the company has released via the ASX.

So, I am still interested in your views.

Please provide some commentry on the difference between the chance of success of Bisantrene, a previously approved molecule with positive results (has form), versus a completely new molecule under trial with no previous results trying to make it.

What to do you say about the fact that Race has funded all planned trials, whose results will determine the clinical success or otherwise of Bisantrene? i.e. the plan/course is set and Dr T only needs to to keep the Race ship on course. Not an easy task, but somehting I think he is good at.

Again, I look forward to your robust discussion.
Please show me you have more depth in you than "Oh look! a director is posting on HC"

Merry Christmas all.
Its time to go make some gravy.